Back

Impact of diabetes mellitus on clinical outcomes after percutaneous coronary intervention for chronic total occlusions in the drug-eluting stent era: a systematic review and meta-analysis

30 August 2026 (09:15 - 09:45)
Organised by: Logo
Congress Presentation Part of: Diabetes and the heart: percutaneous coronary intervention and outcomes Percutaneous Coronary Intervention (PCI) and Surgery ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Guilherme Spina

Heart Institute of the University of Sao Paulo (InCor), Sao Paulo (Brazil)

4 More presentations in this session

Presentation thumbnail
Diabetes mellitus and 10-year outcomes after percutaneous coronary intervention with drug eluting stents: insights from the DECADE cooperation
Doctor M. Immobile Molaro (Munich, DE)
Abstract Slides
Presentation thumbnail
Association of mitochondrial DNA copy number with prior myocardial infarction in patients with coronary artery disease and type 2 diabetes
Doctor Y. Dzhun (Kiev, UA)
Abstract Slides
Presentation thumbnail
Pre-procedural urine albumin-to-creatinine ratio and one-year major adverse cardiovascular events following percutaneous coronary intervention
Mr V. Zhang (US)
Abstract Slides
Presentation thumbnail
Socioeconomic disparities in 1-year outcomes after PCI.
Ms S. Janssen (Heerlen, NL)
Abstract Slides

Access the full session

Session thumbnail
Diabetes and the heart: percutaneous coronary intervention and outcomes

The Event

Event poster

ESC Congress 2026

30 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
The impact of chronic total occlusions in patient outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis
1 September 2025
thumbnail
Congress Presentation
Coronary stent failure in patients with type 1 and type 2 diabetes: a nationwide observational study
1 September 2025
thumbnail
Congress Presentation
Meta-analysis of cardiovascular outcome trials assessing the cardiovascular efficacy and safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus
27 August 2021
thumbnail
Congress Presentation
Reduced chest pain and quality-of-life and improvement after tailored therapy in diabetic patients with ischaemia with non-obstructive coronary arteries: findings from the INOCA-IT Registry
20 February 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources